non targeting control sequence (Addgene inc)
Structured Review
Non Targeting Control Sequence, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 33 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/control+grna+sequence/non-targeting+control+gRNA+(BRDN0001145598)+(Plasmid+%2380173)/pm40446642-218-20-36
Average 94 stars, based on 33 article reviews
Images
Related Articles
Control:Article Title: DPPA4 increases aggressiveness of pituitary neuroendocrine tumors by enhancing cell stemness. Article Snippet: © The Author(s) 2024.. Published by Oxford University Press on behalf of the Society for NeuroOncology.. This is an Open Access article distributed under the terms of the Creative Commons AttributionNonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits noncommercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. Article Title: Developmental pluripotency-associated 4 increases aggressiveness of pituitary neuroendocrine tumors by enhancing cell stemness Article Snippet: .. Eleven target gRNA sequences and 1 Article Title: Transcription Factor 4 loss-of-function is associated with deficits in progenitor proliferation and cortical neuron content. Article Snippet: .. As a Sequencing:Article Title: DPPA4 increases aggressiveness of pituitary neuroendocrine tumors by enhancing cell stemness. Article Snippet: © The Author(s) 2024.. Published by Oxford University Press on behalf of the Society for NeuroOncology.. This is an Open Access article distributed under the terms of the Creative Commons AttributionNonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits noncommercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. Article Title: Developmental pluripotency-associated 4 increases aggressiveness of pituitary neuroendocrine tumors by enhancing cell stemness Article Snippet: .. Eleven target gRNA sequences and 1 Article Title: Transcription Factor 4 loss-of-function is associated with deficits in progenitor proliferation and cortical neuron content. Article Snippet: .. As a Clone Assay:Article Title: DPPA4 increases aggressiveness of pituitary neuroendocrine tumors by enhancing cell stemness. Article Snippet: © The Author(s) 2024.. Published by Oxford University Press on behalf of the Society for NeuroOncology.. This is an Open Access article distributed under the terms of the Creative Commons AttributionNonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits noncommercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. Article Title: Developmental pluripotency-associated 4 increases aggressiveness of pituitary neuroendocrine tumors by enhancing cell stemness Article Snippet: .. Eleven target gRNA sequences and 1 Plasmid Preparation:Article Title: DPPA4 increases aggressiveness of pituitary neuroendocrine tumors by enhancing cell stemness. Article Snippet: © The Author(s) 2024.. Published by Oxford University Press on behalf of the Society for NeuroOncology.. This is an Open Access article distributed under the terms of the Creative Commons AttributionNonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits noncommercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. Article Title: Developmental pluripotency-associated 4 increases aggressiveness of pituitary neuroendocrine tumors by enhancing cell stemness Article Snippet: .. Eleven target gRNA sequences and 1 Article Title: Transcription Factor 4 loss-of-function is associated with deficits in progenitor proliferation and cortical neuron content. Article Snippet: .. As a CRISPR:Article Title: Transcription Factor 4 loss-of-function is associated with deficits in progenitor proliferation and cortical neuron content. Article Snippet: .. As a |

